<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-99178</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency</dc:title>
<dc:creator>Hou, F. F</dc:creator>
<dc:creator>Fernández Juárez, G</dc:creator>
<dc:creator>Jiang, J. P</dc:creator>
<dc:creator>Zhang, W. R</dc:creator>
<dc:creator>Liang, M</dc:creator>
<dc:creator>Guo, Z. J</dc:creator>
<dc:creator>Xie, D</dc:creator>
<dc:creator>Zhang, X</dc:creator>
<dc:creator>Barrio, V</dc:creator>
<dc:creator>Chen, P. Y</dc:creator>
<dc:language>es</dc:language>
<dc:source>Nefrologia;28(supl.2): 16-17, ene.-dic. 2008. ilus</dc:source>
<dc:identifier>ibc-99178</dc:identifier>
<dc:title xml:lang="es">¿Las dosis óptimas para reducir la proteinuria de benazepril y losartán son más nefroprotectoras que ladosis convencional en nefropatías proteinúricas no diabéticas?</dc:title>
<dc:subject>^d50495^s22057</dc:subject>
<dc:subject>^d33405^s22079</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d962^s22079</dc:subject>
<dc:subject>^d11946^s22057</dc:subject>
<dc:subject>^d54125^s22079</dc:subject>
<dc:type>article</dc:type>
<dc:date>200812</dc:date>
</metadata>
</record>
</ibecs-document>
